ATE195866T1 - Zweiphasige multilamellare lipidvesikel - Google Patents

Zweiphasige multilamellare lipidvesikel

Info

Publication number
ATE195866T1
ATE195866T1 AT94922214T AT94922214T ATE195866T1 AT E195866 T1 ATE195866 T1 AT E195866T1 AT 94922214 T AT94922214 T AT 94922214T AT 94922214 T AT94922214 T AT 94922214T AT E195866 T1 ATE195866 T1 AT E195866T1
Authority
AT
Austria
Prior art keywords
lipid
phase
multilamellar lipid
lipid vesicles
multilamellar
Prior art date
Application number
AT94922214T
Other languages
English (en)
Inventor
Marianna Foldvari
Original Assignee
Pharmaderm Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaderm Lab Ltd filed Critical Pharmaderm Lab Ltd
Application granted granted Critical
Publication of ATE195866T1 publication Critical patent/ATE195866T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
AT94922214T 1993-07-28 1994-07-28 Zweiphasige multilamellare lipidvesikel ATE195866T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9810293A 1993-07-28 1993-07-28
PCT/CA1994/000409 WO1995003787A1 (en) 1993-07-28 1994-07-28 Biphasic multilamellar lipid vesicles

Publications (1)

Publication Number Publication Date
ATE195866T1 true ATE195866T1 (de) 2000-09-15

Family

ID=22267097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94922214T ATE195866T1 (de) 1993-07-28 1994-07-28 Zweiphasige multilamellare lipidvesikel

Country Status (10)

Country Link
EP (1) EP0711148B1 (de)
AT (1) ATE195866T1 (de)
AU (1) AU7343894A (de)
CA (1) CA2168260C (de)
DE (1) DE69425750T2 (de)
DK (1) DK0711148T3 (de)
ES (1) ES2152324T3 (de)
GR (1) GR3034777T3 (de)
PT (1) PT711148E (de)
WO (1) WO1995003787A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3901213B2 (ja) * 1994-08-05 2007-04-04 インファルマ・ソシエテ・アノニム ホスファチジルコリンとプロスタグランジンｅ１及び／又はトロキサールチンとの複合体を含有する、勃起不能の局所治療のための製剤
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
EP1677765A1 (de) * 2003-10-24 2006-07-12 Alza Corporation Herstellung von lipidteilchen
EP2034961A1 (de) * 2006-06-30 2009-03-18 Gertrud Langhoff Solubilisatformulierungen
HUE033256T2 (hu) * 2007-03-30 2017-11-28 Xisle Pharma Ventures Trust Kétfázisú lipidvezikulum készítmény és eljárás cervikális diszplázia kezelésére intravaginális adagolással
FR2939313B1 (fr) * 2008-12-10 2012-03-23 St Hubert Procede de preparation de vesicules a caractere hydrophobe comprenant une cavite interne hydrophobe.
US20120021036A1 (en) * 2009-01-15 2012-01-26 The Regents Of The University Of California Composite nanostructures and methods for making and using them
GB201202333D0 (en) * 2012-02-10 2012-03-28 Stepan Co Structured surfactant suspending systems
US9668474B2 (en) 2012-02-10 2017-06-06 Stepan Company Structured surfactant suspending systems
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US10159646B2 (en) * 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
JP6533297B2 (ja) * 2014-12-30 2019-06-19 セルトリオン・インコーポレイテッド 表皮成長因子とリポソームのハイブリッド型多層ナノ構造体及びその製造方法
WO2018050864A1 (en) 2016-09-15 2018-03-22 Camurus Ab Prostacyclin analogue formulations
CN111093633A (zh) * 2017-05-26 2020-05-01 奥特姆医药公司 双相大麻素递送
EP3810182A4 (de) 2018-06-19 2022-08-24 BioNTech US Inc. Neoantigene und ihre verwendungen
TWI848045B (zh) * 2019-01-30 2024-07-11 德商巴地斯顏料化工廠 供個人護理應用之液晶脂質顆粒之化妝品組合物
MX2022003446A (es) 2019-09-23 2022-07-13 Dds Res Inc Composiciones de vesiculas lipidicas con agentes potenciadores de la penetracion.
KR20240035939A (ko) 2021-03-24 2024-03-19 글로 파마, 인크. 피부 색소침착을 감소시키기 위한 펩타이드 및 방법
WO2023081259A2 (en) * 2021-11-04 2023-05-11 Glo Pharma, Inc. Methods and compositions for cosmetic applications
CN115531319B (zh) * 2022-11-25 2023-05-05 仙乐健康科技股份有限公司 一种高稳定性脂质体及其制备方法和用途
WO2025121442A2 (en) * 2023-12-05 2025-06-12 L'oreal Stable composition with excellent texture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
IL94103A0 (en) * 1989-04-25 1991-01-31 Nattermann A & Cie Water-containing formulations with phospholipids,their preparation and application
WO1991001719A1 (en) * 1989-08-01 1991-02-21 The University Of Michigan Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence

Also Published As

Publication number Publication date
GR3034777T3 (en) 2001-02-28
CA2168260A1 (en) 1995-02-09
WO1995003787A1 (en) 1995-02-09
CA2168260C (en) 2000-04-11
AU7343894A (en) 1995-02-28
EP0711148A1 (de) 1996-05-15
EP0711148B1 (de) 2000-08-30
DE69425750D1 (de) 2000-10-05
DK0711148T3 (da) 2001-01-02
ES2152324T3 (es) 2001-02-01
DE69425750T2 (de) 2001-04-26
PT711148E (pt) 2001-02-28

Similar Documents

Publication Publication Date Title
ATE195866T1 (de) Zweiphasige multilamellare lipidvesikel
DK433484A (da) Medikamentholdigt lipidvesikelpraeparat
ES8603264A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco
DE69530368D1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
AU6319698A (en) Liposomes containing active agents
CA2196780A1 (en) A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents
CA2213861A1 (en) Method for loading lipid vesicles
CA2201120A1 (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
BR9508913A (pt) Preparação de lipossomas multivesiculares para liberação controlada de agentes ativos
ZA939802B (en) Cosmetic delivery system for salicyclic acid and process for preparation of the same.
PL334940A1 (en) Lipoid complexes and liposomes of highly insoluble platinum complexes
NZ503568A (en) Biphasic lipid vesicle composition for transdermal administration of an immunogen
FI971494L (fi) Eetterilipidiloposomit sekä niiden terapeuttinen käyttö
ES2134846T3 (es) Formulacion de antibiotico y uso para infecciones resistentes a farmacos.
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
EP0198765A3 (de) Herstellung von Liposomen
GB2303791B (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
NO973666D0 (no) Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom
DE69520231D1 (de) Liposomzubereitungen enthaltend hybrid-interferon
WO1997004811A3 (de) Verwendung von liposomalen zubereitungen in der indirekten mrt-lymphographie
FI970935A0 (fi) Terapeutiskt anvaendbara eterlipider och foerfaranden foer deras framstaellning
IL105685A (en) Multi-layered, microencapsulated pharmaceutical composition
NO963942D0 (no) Liposomer inneholdende kontrastmidler
ES8600055A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification